Immunovant
IMVT
IMVT
209 hedge funds and large institutions have $2.27B invested in Immunovant in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 82 increasing their positions, 79 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $2.9B → $2.27B (-$631M)
39% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 46
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
209
Holding in Top 10
5
Calls
$42.8M
Puts
$23.4M
Top Buyers
| 1 | +$58.5M | |
| 2 | +$25.8M | |
| 3 | +$23.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21M |
| 5 |
PA
Perceptive Advisors
New York
|
+$20.5M |
Top Sellers
| 1 | -$49.1M | |
| 2 | -$41.5M | |
| 3 | -$39.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.8M |
| 5 |
Jane Street
New York
|
-$17.7M |